Prenetics Global (PRE) Income from Non-Controlling Interests (2021 - 2025)
Prenetics Global (PRE) reported Income from Non-Controlling Interests of -$42000.0 for Q4 2025, up 96.91% year-over-year from -$21329.6 in Q4 2024, and up 96.73% quarter-over-quarter from -$1.3 million in Q3 2025.
Prenetics Global (PRE) Income from Non-Controlling Interests (2021 - 2025) Analysis & Trends
Prenetics Global (PRE) has 5 years of Income from Non-Controlling Interests data on file, last reported at -$42000.0 in Q4 2025.
- Income from Non-Controlling Interests for Q4 2025 came in at -$42000.0, up 96.91% year-over-year; the trailing twelve-month figure through Dec 2025 was -$3.4 million (down 20.66% YoY), and the FY2025 annual result was -$93000.0, down 109.72% from the prior year.
- Income from Non-Controlling Interests climbed to -$42000.0 in Q4 2025 per PRE's latest filing, from -$1.3 million in the prior quarter.
- Over five years, Income from Non-Controlling Interests peaked at $5.3 million in Q1 2023 and troughed at -$1.4 million in Q4 2024.
- A 5-year average of $439084.3 and a median of -$2559.0 in 2021 frame the typical range for Income from Non-Controlling Interests.
- On a YoY basis, Income from Non-Controlling Interests climbed as much as 54362600.0% in 2023 and fell as far as 56827700.0% in 2023.
- A 5-year view of Income from Non-Controlling Interests shows it stood at -$27.0 in 2021, then soared by 103.7% to $1.0 in 2022, then plunged by 56827700.0% to -$568276.0 in 2023, then slumped by 139.14% to -$1.4 million in 2024, then surged by 96.91% to -$42000.0 in 2025.
- Business Quant data shows PRE's Income from Non-Controlling Interests at -$42000.0 in Q4 2025, -$1.3 million in Q3 2025, and -$90000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | - |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 5.00 Mn |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | - |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | - |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | - |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | - |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | 1.00 Mn |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | - |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | - |
| 10 | Prenetics Global | 520,750.00 | -62.80 Mn | 21.74 Mn | -42,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -42,000.00 |
| Sep 30, 2025 | -1.29 Mn |
| Jun 30, 2025 | -90,000.00 |
| Mar 31, 2025 | -706,000.00 |
| Dec 31, 2024 | -1.36 Mn |
| Sep 30, 2024 | 1.42 Mn |
| Jun 30, 2024 | 2.76 Mn |
| Mar 31, 2024 | -484,000.00 |
| Dec 31, 2023 | -568,276.00 |
| Sep 30, 2023 | 4.35 Mn |
| Jun 30, 2023 | -399,877.00 |
| Mar 31, 2023 | 5.28 Mn |
| Dec 31, 2022 | 1.00 |
| Sep 30, 2022 | -8.00 |
| Jun 30, 2022 | -1.00 |
| Mar 31, 2022 | -85,021.00 |
| Dec 31, 2021 | -27.00 |
| Sep 30, 2021 | -2,424.00 |
| Jun 30, 2021 | -2,673.00 |
| Mar 31, 2021 | -2,445.00 |